Desktop Site |
23 Apr 24 | 13:03 | Open
Equity SME Eq Drv Currency Commodity Corporates
Get Quote
Notices |
S&P BSE SENSEX 73,848.03 +199.41 +0.27 %
Corporate Announcement
  • Security Code532321
    CompanyZydus Lifesciences Ltd
    Exchange Received Time17/06/2019 14:38:57
    Exchange Disseminated Time17/06/2019 14:38:59
    Time Taken00:00:02
     
     
     Announcement under Regulation 30 (LODR)-Press Release / Media Release | 6/17/2019 2:38:57 PM 
     Zydus Announces Completion of Enrolment in EVIDENCES IV Phase 2 Clinical Trial of Saroglitazar Magnesium in NASH 
    AttachmentDownload PDF
     
    << Back  
     
Recently Viewed
Copyright@ 2015. All Rights Reserved. BSE Ltd.
(11H) 23 Apr 24|13:03 (IST)